Tianjin Tianyao Pharmaceuticals Co Ltd (600488) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥13.19 Million ≈ $1.93 Million USD) by net assets (CN¥3.89 Billion ≈ $569.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Tianjin Tianyao Pharmaceuticals Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Tianjin Tianyao Pharmaceuticals Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Tianjin Tianyao Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tianjin Tianyao Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tianjin Tianyao Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency. Explore Tianjin Tianyao Pharmaceuticals Co Ltd (600488) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GuoChuang Software Co Ltd
SHE:300520
|
0.008x |
|
Amerant Bancorp Inc.
NYSE:AMTB
|
0.024x |
|
Procter & Gamble Health Limited
NSE:PGHL
|
0.278x |
|
Amphastar P
NASDAQ:AMPH
|
0.067x |
|
Montnets Cloud Technology Group Co Ltd
SHE:002123
|
0.033x |
|
Crystal Growth & Energy Equipment Co. Ltd. A
SHG:688478
|
N/A |
|
Hainan Development Holdings Nanhai Co Ltd
SHE:002163
|
-0.094x |
|
Plymouth Industrial REIT Inc
NYSE:PLYM
|
0.036x |
Annual Cash Flow Conversion Efficiency for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
The table below shows the annual cash flow conversion efficiency of Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. View Tianjin Tianyao Pharmaceuticals Co Ltd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.89 Billion ≈ $568.62 Million |
CN¥569.37 Million ≈ $83.32 Million |
0.147x | -29.76% |
| 2023-12-31 | CN¥3.75 Billion ≈ $549.23 Million |
CN¥783.01 Million ≈ $114.58 Million |
0.209x | +19.83% |
| 2022-12-31 | CN¥3.75 Billion ≈ $549.30 Million |
CN¥653.52 Million ≈ $95.63 Million |
0.174x | +109.69% |
| 2021-12-31 | CN¥3.82 Billion ≈ $558.53 Million |
CN¥316.89 Million ≈ $46.37 Million |
0.083x | -9.71% |
| 2020-12-31 | CN¥3.77 Billion ≈ $552.05 Million |
CN¥346.88 Million ≈ $50.76 Million |
0.092x | +18.02% |
| 2019-12-31 | CN¥3.59 Billion ≈ $524.74 Million |
CN¥279.37 Million ≈ $40.88 Million |
0.078x | +35.10% |
| 2018-12-31 | CN¥3.28 Billion ≈ $480.28 Million |
CN¥189.27 Million ≈ $27.70 Million |
0.058x | +2315.44% |
| 2017-12-31 | CN¥3.13 Billion ≈ $457.91 Million |
CN¥-8.15 Million ≈ $-1.19 Million |
-0.003x | -110.24% |
| 2016-12-31 | CN¥2.49 Billion ≈ $364.44 Million |
CN¥63.32 Million ≈ $9.27 Million |
0.025x | -51.92% |
| 2015-12-31 | CN¥2.45 Billion ≈ $358.33 Million |
CN¥129.50 Million ≈ $18.95 Million |
0.053x | -29.13% |
| 2014-12-31 | CN¥2.40 Billion ≈ $350.53 Million |
CN¥178.76 Million ≈ $26.16 Million |
0.075x | +105.28% |
| 2013-12-31 | CN¥2.33 Billion ≈ $340.36 Million |
CN¥84.55 Million ≈ $12.37 Million |
0.036x | +385.84% |
| 2012-12-31 | CN¥1.77 Billion ≈ $258.69 Million |
CN¥13.23 Million ≈ $1.94 Million |
0.007x | -83.92% |
| 2011-12-31 | CN¥1.69 Billion ≈ $246.84 Million |
CN¥78.47 Million ≈ $11.48 Million |
0.047x | -35.03% |
| 2010-12-31 | CN¥1.63 Billion ≈ $238.75 Million |
CN¥116.82 Million ≈ $17.09 Million |
0.072x | -74.40% |
| 2009-12-31 | CN¥1.56 Billion ≈ $227.69 Million |
CN¥435.13 Million ≈ $63.67 Million |
0.280x | +91.77% |
| 2008-12-31 | CN¥1.50 Billion ≈ $220.07 Million |
CN¥219.31 Million ≈ $32.09 Million |
0.146x | +31.22% |
| 2007-12-31 | CN¥1.46 Billion ≈ $213.75 Million |
CN¥162.33 Million ≈ $23.75 Million |
0.111x | +136.07% |
| 2006-12-31 | CN¥1.08 Billion ≈ $157.67 Million |
CN¥50.72 Million ≈ $7.42 Million |
0.047x | +145.17% |
| 2005-12-31 | CN¥1.04 Billion ≈ $152.86 Million |
CN¥-108.87 Million ≈ $-15.93 Million |
-0.104x | -193.30% |
| 2004-12-31 | CN¥987.47 Million ≈ $144.50 Million |
CN¥110.30 Million ≈ $16.14 Million |
0.112x | +128.34% |
| 2003-12-31 | CN¥935.65 Million ≈ $136.92 Million |
CN¥45.77 Million ≈ $6.70 Million |
0.049x | -15.24% |
| 2002-12-31 | CN¥784.51 Million ≈ $114.80 Million |
CN¥45.28 Million ≈ $6.63 Million |
0.058x | -42.62% |
| 2001-12-31 | CN¥714.63 Million ≈ $104.57 Million |
CN¥71.87 Million ≈ $10.52 Million |
0.101x | -48.14% |
| 2000-12-31 | CN¥211.75 Million ≈ $30.99 Million |
CN¥41.06 Million ≈ $6.01 Million |
0.194x | -- |
About Tianjin Tianyao Pharmaceuticals Co Ltd
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company's primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid r… Read more